Catel-Manzke syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1388OMIM:616145Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Catel-Manzke syndrome (also known as index finger anomaly with Pierre Robin syndrome, or palatodigital syndrome) is a rare congenital disorder characterized by the combination of Pierre Robin sequence (micrognathia, glossoptosis, and cleft palate) with a distinctive bilateral hyperphalangy of the index fingers. The extra bone (accessory ossicle) is located at the base of the index finger on the radial side, causing the finger to deviate toward the thumb side (radial clinodactyly). This unique hand anomaly is considered the hallmark feature of the syndrome and helps distinguish it from isolated Pierre Robin sequence. The condition primarily affects the craniofacial structures and the skeletal system, particularly the hands. Affected infants often present at birth with significant breathing and feeding difficulties due to the small jaw and tongue displacement. Congenital heart defects, including atrial and ventricular septal defects, have been reported in some patients and represent an important associated feature. Joint hypermobility and short stature may also occur. Intelligence is typically normal, though developmental delays have been described in some cases. Treatment is symptomatic and supportive. Management of the Pierre Robin sequence may include prone positioning, nasopharyngeal airways, or in severe cases, mandibular distraction osteogenesis or tracheostomy to secure the airway. Cleft palate repair is performed surgically, usually in the first year of life. The index finger anomaly generally improves with age and often does not require surgical intervention, as the accessory bone may fuse spontaneously. Cardiac defects, when present, are managed according to standard cardiological protocols. Long-term prognosis is generally favorable with appropriate early management.

Also known as:

Clinical phenotype terms— hover any for plain English:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Catel-Manzke syndrome.

View clinical trials →

No actively recruiting trials found for Catel-Manzke syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Catel-Manzke syndrome community →

No specialists are currently listed for Catel-Manzke syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Catel-Manzke syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Catel-Manzke syndromeForum →

No community posts yet. Be the first to share your experience with Catel-Manzke syndrome.

Start the conversation →

Latest news about Catel-Manzke syndrome

No recent news articles for Catel-Manzke syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Catel-Manzke syndrome

What is Catel-Manzke syndrome?

Catel-Manzke syndrome (also known as index finger anomaly with Pierre Robin syndrome, or palatodigital syndrome) is a rare congenital disorder characterized by the combination of Pierre Robin sequence (micrognathia, glossoptosis, and cleft palate) with a distinctive bilateral hyperphalangy of the index fingers. The extra bone (accessory ossicle) is located at the base of the index finger on the radial side, causing the finger to deviate toward the thumb side (radial clinodactyly). This unique hand anomaly is considered the hallmark feature of the syndrome and helps distinguish it from isolated

How is Catel-Manzke syndrome inherited?

Catel-Manzke syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Catel-Manzke syndrome typically begin?

Typical onset of Catel-Manzke syndrome is neonatal. Age of onset can vary across affected individuals.